Literature DB >> 27748885

Interaction between Treg cells and tumor-associated macrophages in the tumor microenvironment of epithelial ovarian cancer.

Qinyi Zhu1, Xiaoli Wu1, Yueqian Wu1, Xipeng Wang1.   

Abstract

Epithelial ovarian cancer (EOC) is the most lethal gynecological malignancy. Inflammatory cells in the EOC microenvironment play a key role in tumor progression. In the present study, we investigated the mechanism of the accumulation of regulatory T cells (Tregs) induced by interleukin-10 (IL-10) derived from tumor-associated macrophages (TAMs) in the EOC microenvironment. The frequency of Tregs and TAMs was detected by immunofluorescence in 40 EOC tissues and 20 benign ovarian tumors, as well as the expression of IL-10 which was assessed by immunohistochemistry. It was found that the frequency of Treg cells and TAMs was significantly higher in the EOC than those in the benign ovarian tumors. The expression of IL-10 was also found to be higher in the EOC than that in the benign tumors. EOC patients with a high frequency of Tregs exhibited a significantly shorter overall survival time compared to those with a low frequency of Tregs. In addition, the expression of IL-10 in ascites and blood serum and the IL-10 released in the co-cultured system supernatants were detected by ELISA. Following CD4+ T-cell co-culturing with macrophages and IL-10, it was observed by flow cytometric analysis that the frequency of Treg cells was increased in the presence of IL-10. It was also established that IL-10 released in the co-cultured supernatants was increased. We also detected the mechanism of Treg cells induced by IL-10 in vivo. The SKOV3 cell tumor volume and weight were much higher in the presence of IL-10 in a mouse subcutaneous model. These data suggest that IL-10 secreted by TAMs increase the frequency of Treg cells through the activation of Foxp3 during T-cell differentiation and promotes tumor progression.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27748885     DOI: 10.3892/or.2016.5136

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  22 in total

Review 1.  Friend and foe: the regulation network of ascites components in ovarian cancer progression.

Authors:  Zhe Geng; Xinxing Pan; Juan Xu; Xuemei Jia
Journal:  J Cell Commun Signal       Date:  2022-10-13       Impact factor: 5.908

Review 2.  Electroporation and Immunotherapy-Unleashing the Abscopal Effect.

Authors:  Tobias Freyberg Justesen; Adile Orhan; Hans Raskov; Christian Nolsoe; Ismail Gögenur
Journal:  Cancers (Basel)       Date:  2022-06-10       Impact factor: 6.575

3.  Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity.

Authors:  Peter C Hart; Preety Bajwa; Hilary A Kenny
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  In-situ vaccination using focused ultrasound heating and anti-CD-40 agonistic antibody enhances T-cell mediated local and abscopal effects in murine melanoma.

Authors:  Mohit Pratap Singh; Sri Nandhini Sethuraman; Jerry Ritchey; Steven Fiering; Chandan Guha; Jerry Malayer; Ashish Ranjan
Journal:  Int J Hyperthermia       Date:  2019-11       Impact factor: 3.914

Review 5.  Exosomal MicroRNAs as Mediators of Cellular Interactions Between Cancer Cells and Macrophages.

Authors:  Yoojung Kwon; Misun Kim; Youngmi Kim; Hyun Suk Jung; Dooil Jeoung
Journal:  Front Immunol       Date:  2020-06-11       Impact factor: 7.561

Review 6.  Revisiting ovarian cancer microenvironment: a friend or a foe?

Authors:  Boyi Zhang; Fei Chen; Qixia Xu; Liu Han; Jiaqian Xu; Libin Gao; Xiaochen Sun; Yiwen Li; Yan Li; Min Qian; Yu Sun
Journal:  Protein Cell       Date:  2017-09-19       Impact factor: 14.870

Review 7.  Role of tumor microenvironment in the pathobiology of ovarian cancer: Insights and therapeutic opportunities.

Authors:  Alia Ghoneum; Hesham Afify; Ziyan Salih; Michael Kelly; Neveen Said
Journal:  Cancer Med       Date:  2018-08-21       Impact factor: 4.452

8.  Cognate Interaction With CD4+ T Cells Instructs Tumor-Associated Macrophages to Acquire M1-Like Phenotype.

Authors:  David Eisel; Krishna Das; Elke Dickes; Rainer König; Wolfram Osen; Stefan B Eichmüller
Journal:  Front Immunol       Date:  2019-02-22       Impact factor: 7.561

9.  The resveratrol analogue, HS‑1793, enhances the effects of radiation therapy through the induction of anti‑tumor immunity in mammary tumor growth.

Authors:  Joong Sun Kim; Soo Kyung Jeong; Su Jung Oh; Chang Geun Lee; Yeong Rok Kang; Wol Soon Jo; Min Ho Jeong
Journal:  Int J Oncol       Date:  2020-03-19       Impact factor: 5.650

Review 10.  Signaling of Macrophages that Contours the Tumor Microenvironment for Promoting Cancer Development.

Authors:  Justin K Messex; Crystal J Byrd; Geou-Yarh Liou
Journal:  Cells       Date:  2020-04-09       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.